| BIOT | Wednesday, August 22, 2007 | ||
8:00 AM-11:00 AM BCEC -- 106, Oral | |||
Commercialization of Biologics: Characterization and Improvement of Platforms to Aid Commercialization of Biologics | |||
| Organizers: | Shishir Gadam Frank Olsen | ||
| 8:00 AM | 192 | A systems approach to characterization, validation and monitoring of commercial processes Abhinav A Shukla, Steven Lee | |
| 8:20 AM | 193 | Systematic and logical strategies to reduce process scale-up and technology transfer challenges from process development to manufacturing Tsu-shun Lee, Monica McGill, Peter Thompson | |
| 8:40 AM | 194 | Evaluation of process and product impact of UVC treatment on a MAb process R. Scott Rosenthal | |
| 9:00 AM | 195 | Viral clearance strategies using improved membrane adsorbers William T. Riordan, Mark R Etzel | |
| 9:20 AM | Intermission | ||
| 9:40 AM | 196 | Standardization of purification process development for mAbs & Fc-fusion proteins Ranga Godavarti, Glen Bolton, James Booth, Paul R Brown, Jon Coffman, Connie Esenther, Chris Gallo, T Iskra, Shujun Sun, Mary Switzer, Scott A Tobler, Richard Wright, Brian Kelley | |
| 10:00 AM | 197 | Characterization of a reversed phase chromatography step Xiaochun Hu, Alice Wang, Yuefeng Lu, Oliver Kaltenbrunner | |
| 10:20 AM | 198 | Strategies for maximizing the clearance of impurities across an anion exchange flow through step in the context of an integrated antibody purification process Amitava Kundu, Amy Miller, Jerrod Einerwold, Michelle Xia, Robert Duffy, Weichang Zhou | |
| 10:40 AM | 199 | Platform ultrafiltration process development: Charge and conductivity effects on ultrafiltration performance of monoclonal antibodies Amy S Len, Robert van Reis | |
Commercialization of Biologics: Characterization and Improvement of Platforms to Aid Commercialization of Biologics -- Next Session
Symposium Grid -- Division of Biochemical Technology -- Session Listing
The 234th ACS National Meeting, Boston, MA, August 19-23, 2007